In three recent studies a new drug is showing real promise in helping people quit smoking. It's called Chantix and it won FDA approval earlier this summer.
Chantix is not a nicotine replacement instead, it targets the same area of the brain that is affected by nicotine. Meaning it stimulates the brain to release dopamine which helps ease the cravings, then, it blocks the effects of nicotine if the smoker lights up again.
A third of the patients suffered from nausea as a side effect. That may be a problem. But in all three studies, Chantix was significantly more effective than the other leading anti-smoking pill on the market called Zyban.